{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T14:54:22Z","timestamp":1776351262096,"version":"3.51.2"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004792","name":"Minist\u00e8re de l'Enseignement Sup\u00e9rieur et de la Recherche","doi-asserted-by":"publisher","award":["D50675"],"award-info":[{"award-number":["D50675"]}],"id":[{"id":"10.13039\/501100004792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Hereditary Hemorrhagic Telangiectasia (HHT) is an autosomal dominant disorder characterized by multiple telangiectases and caused by germline disease-causing variants in the<jats:italic>ENG (HHT1)<\/jats:italic>,<jats:italic>ACVRL1 (HHT2)<\/jats:italic>and, to a lesser extent<jats:italic>MADH4<\/jats:italic>and<jats:italic>GDF2<\/jats:italic>, which encode proteins involved in the TGF-\u03b2\/BMP9 signaling pathway. Common visceral complications of HHT are caused by pulmonary, cerebral, or hepatic arteriovenous malformations (HAVMs). There is large intrafamilial variability in the severity of visceral involvement, suggesting a role for modifier genes. The objective of the present study was to investigate the potential role of<jats:italic>ENG<\/jats:italic>,<jats:italic>ACVRL1<\/jats:italic>, and of other candidate genes belonging to the same biological pathway in the development of HAVMs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We selected 354 patients from the French HHT patient database who had one disease causing variant in either<jats:italic>ENG<\/jats:italic>or<jats:italic>ACVRL1<\/jats:italic>and who underwent hepatic exploration. We first compared the distribution of the different types of variants with the occurrence of HAVMs. Then, we genotyped 51 Tag-SNPs from the Hap Map database located in 8 genes that encode proteins belonging to the TGF-\u03b2\/BMP9 pathway (<jats:italic>ACVRL1, ENG, GDF2, MADH4, SMAD1, SMAD5, TGFB1, TGFBR1<\/jats:italic>), as well as in two additional candidate genes (<jats:italic>PTPN14<\/jats:italic>and<jats:italic>ADAM17<\/jats:italic>). We addressed the question of a possible genetic association with the occurrence of HAVMs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The proportion of patients with germline<jats:italic>ACVRL1<\/jats:italic>variants and the proportion of women were significantly higher in HHT patients with HAVMs. In the HHT2 group, HAVMs were more frequent in patients with truncating variants. Six SNPs (3 in<jats:italic>ACVRL1<\/jats:italic>, 1 in<jats:italic>ENG<\/jats:italic>, 1 in<jats:italic>SMAD5<\/jats:italic>, and 1 in<jats:italic>ADAM17<\/jats:italic>) were significantly associated with HAVMs. After correction for multiple testing, only one remained significantly associated (rs2277383).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this large association study, we confirmed the strong relationship between<jats:italic>ACVRL1<\/jats:italic>and the development of HAVMs. Common polymorphisms of<jats:italic>ACVRL1<\/jats:italic>may also play a role in the development of HAVMs, as a modifying factor, independently of the disease-causing variants.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13023-020-01533-2","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T06:02:46Z","timestamp":1600754566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Sequence variations of ACVRL1 play a critical role in hepatic vascular malformations in hereditary hemorrhagic telangiectasia"],"prefix":"10.1186","volume":"15","author":[{"given":"Sophie","family":"Giraud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Bardel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Dupuis-Girod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-France","family":"Carette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Gilbert-Dussardier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Riviere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Christophe","family":"Saurin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Eyries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Patri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyne","family":"Decullier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Calender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7691-9492","authenticated-orcid":false,"given":"Ga\u00ebtan","family":"Lesca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"key":"1533_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ajmg.1320320302","volume":"32","author":"H Plauchu","year":"1989","unstructured":"Plauchu H, de Chadarevian JP, Bideau A, Robert JM. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet. 1989;32:291\u20137.","journal-title":"Am J Med Genet"},{"key":"1533_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng1294-345","volume":"8","author":"KA McAllister","year":"1994","unstructured":"McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, et al. Endoglin, a TGF-\u03b2 binding protein of endothelial cells, is the gene for hereditary hemorrhagic telangiectasia type 1. Nat Genet. 1994;8:345\u201351.","journal-title":"Nat Genet"},{"key":"1533_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/ng0696-189","volume":"13","author":"DW Johnson","year":"1996","unstructured":"Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet. 1996;13:189\u201395.","journal-title":"Nat Genet"},{"key":"1533_CR4","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S0140-6736(04)15732-2","volume":"363","author":"CJ Gallione","year":"2004","unstructured":"Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S, et al. A combined syndrome of juvenile polyposis and hereditary hemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet. 2004;363:852\u20139.","journal-title":"Lancet"},{"key":"1533_CR5","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ajhg.2013.07.004","volume":"93","author":"WL Wooderchak-Donahue","year":"2013","unstructured":"Wooderchak-Donahue WL, McDonald J, O\u2019Fallon B, Upton PD, Li W, Roman BL, et al. BMP9 pathogenic variants cause a vasculazt-anomay syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia. Am J Hum Genet. 2013;93:530\u20137.","journal-title":"Am J Hum Genet"},{"key":"1533_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2015.00001","volume":"6","author":"J McDonald","year":"2015","unstructured":"McDonald J, Wooderchak-Donahue W, Van Sant WC, Whitehead K, Stevenson DA, Bayrak-Toydemir P. Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era. Front Genet. 2015;6:1.","journal-title":"Front Genet"},{"key":"1533_CR7","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1086\/379793","volume":"73","author":"I Eerola","year":"2003","unstructured":"Eerola I, Boon LM, Mulliken JB, Burrows PE, Dompmartin A, Watanabe S, et al. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet. 2003;73:1240\u20139.","journal-title":"Am J Hum Genet"},{"key":"1533_CR8","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1161\/CIRCULATIONAHA.116.026886","volume":"136","author":"M Amyere","year":"2017","unstructured":"Amyere M, Revencu N, Helaers R, Pairet E, Baselga E, Cordisco M, et al. Germline loss-of-function mutations in EPHB4 cause a second form of capillary malformation-arteriovenous malformation (CM-AVM2) deregulating RAS-MAPK signaling. Circulation. 2017;136:1037\u201348.","journal-title":"Circulation"},{"key":"1533_CR9","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/jcp.20311","volume":"204","author":"FJ Blanco","year":"2005","unstructured":"Blanco FJ, Santibanez JF, Guerrero-Esteo M, Langa C, Vary CP, Bernabeu C. Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex. J Cell Physiol. 2005;204:574\u201384.","journal-title":"J Cell Physiol"},{"key":"1533_CR10","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1182\/blood-2006-07-034124","volume":"109","author":"L David","year":"2007","unstructured":"David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood. 2007;109:1953\u201361.","journal-title":"Blood"},{"key":"1533_CR11","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jama.2012.250","volume":"307","author":"S Dupuis-Girod","year":"2012","unstructured":"Dupuis-Girod S, Ginon I, Saurin JC, Marion D, Guillot E, Decullier E, et al. Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. JAMA. 2012;307:948\u201355.","journal-title":"JAMA"},{"key":"1533_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1055\/s-0028-1085093","volume":"28","author":"SK Khalid","year":"2008","unstructured":"Khalid SK, Garcia-Tsao G. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia. Semin Liver Dis. 2008;28:247\u201358.","journal-title":"Semin Liver Dis"},{"key":"1533_CR13","doi-asserted-by":"crossref","unstructured":"Berg J, Porteous M, Reinhardt D, Gallione C, Holloway S, Umasunthar T, et al. 2003. Hereditary hemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations. J Med Genet 2003;40:585\u2013590.","DOI":"10.1136\/jmg.40.8.585"},{"key":"1533_CR14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/humu.9311","volume":"25","author":"HK Kuehl","year":"2005","unstructured":"Kuehl HK, Caselitz M, Hasenkamp S, Wagner S, Harith El HA, Manns MP, et al. Hepatic manifestations is associated with ALK1 in hereditary hemorrhagic telangiectasia: identification of five novel ALK1 and one novel ENG mutation. Hum Mutat. 2005;25:320.","journal-title":"Hum Mutat"},{"key":"1533_CR15","first-page":"14","volume":"9","author":"G Lesca","year":"2007","unstructured":"Lesca G, Olivieri C, Burnichon N, Pagella F, Carette MF, Gilbert-Dussardier B, et al. Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French Italian HHT network. Genet Mol. 2007;9:14\u201322.","journal-title":"Genet Mol"},{"key":"1533_CR16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/jmg.2005.035451","volume":"43","author":"TG Letteboer","year":"2006","unstructured":"Letteboer TG, Mager JJ, Snijder RJ, Koeleman BP, Lindhout D, Ploos van Amstel JK, Westermann CJ. Genotype-phenotype-relationship in hereditary hemorrhagic telangiectasia. J Med Genet. 2006;43:371\u20137.","journal-title":"J Med Genet"},{"issue":"5","key":"1533_CR17","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1002\/hep.22514","volume":"48","author":"R Gincul","year":"2008","unstructured":"Gincul R, Lesca G, Gelas-Doe B, Rollin N, Barthelet M, Dupuis-Girod S, et al. Evaluation of previously nonscreened hereditary hemorrhagic telangiectasia patients shows frequent liver involvement and early cardiac consequences. Hepatology. 2008;48(5):1570\u20136.","journal-title":"Hepatology"},{"key":"1533_CR18","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/humu.9421","volume":"27","author":"G Lesca","year":"2006","unstructured":"Lesca G, Burnichon N, Raux G, Tosi M, Pinson S, Marion MJ, et al. Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patients. Hum Mutat. 2006;27:598.","journal-title":"Hum Mutat"},{"key":"1533_CR19","first-page":"163","volume":"21","author":"JC Barret","year":"2005","unstructured":"Barret JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:163\u20135.","journal-title":"Bioinformatics"},{"key":"1533_CR20","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/ncomms1633","volume":"3","author":"M Benzinou","year":"2012","unstructured":"Benzinou M, Clermont FF, Letteboer TG, Kim JH, Espejel S, Harradine KA, et al. Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary hemorrhagic telangiectasia. Nat Commun. 2012;3:616.","journal-title":"Nat Commun"},{"key":"1533_CR21","doi-asserted-by":"publisher","first-page":"7723","DOI":"10.1073\/pnas.1318761111","volume":"111","author":"K Kawasaki","year":"2014","unstructured":"Kawasaki K, Freimuth J, Meyer DS, Lee MM, Tochimoto-Okamoto A, Benzinou M, et al. Genetic variants of Adam17 differentially regulate TGFbeta signaling to modify vascular pathology in mice and humans. Proc Natl Acad Sci U S A. 2014;111:7723\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1533_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2527\/jas.2009-1952","volume":"88","author":"AI Vazquez","year":"2010","unstructured":"Vazquez AI, Bates DM, Rosa GJM, Gianola D, Weigel KA. Technical note: an R package for fitting generalized linear mixed models in animal breeding1. J Anim Sci. 2010;88:497\u2013504.","journal-title":"J Anim Sci"},{"key":"1533_CR23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statistic Soc B. 1995;57:289\u2013300.","journal-title":"J R Statistic Soc B"},{"key":"1533_CR24","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/ejhg.2008.3","volume":"16","author":"G Lesca","year":"2008","unstructured":"Lesca G, Genin E, Blachier C, Olivieri C, Coulet F, Brunet G, et al. Hereditary hemorrhagic telangiectasia: evidence for regional founder effects of ACVRL1 mutations in French and Italian patients. Eur J Hum Genet. 2008;16:742\u20139.","journal-title":"Eur J Hum Genet"},{"key":"1533_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13023-020-1337-5","volume":"16","author":"JM Mora-Lujan","year":"2020","unstructured":"Mora-Lujan JM, Iriarte A, Alba E, Sanchez-Corral MA, Cerda P, Cruellas F, et al. Gender differences in hereditary hemorrhagic telangiectasia severity. Orphanet J Rare Dis. 2020;16:63.","journal-title":"Orphanet J Rare Dis"},{"key":"1533_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/ajmg.a.31101","volume":"140","author":"P Bayrak-Toydemir","year":"2006","unstructured":"Bayrak-Toydemir P, McDonald J, Markewitz B, Lewin S, Miller F, Chou LS, et al. Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations. Am J Med Genet A. 2006;140:463\u201370.","journal-title":"Am J Med Genet A"},{"key":"1533_CR27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3109\/00016489.2011.621145","volume":"132","author":"B Eivazi","year":"2012","unstructured":"Eivazi B, Werner JA, Roessler M, Negm H, Teymoortash A. Lack of significant estrogen and progesterone receptor expression in nasal telangiectasias in hereditary hemorrhagic telangiectasia: an immunohistochemical analysis. Acta Otolaryngol. 2012;132:86\u20139.","journal-title":"Acta Otolaryngol"},{"key":"1533_CR28","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1046\/j.1365-2273.2000.00422-3.x","volume":"25","author":"H Pau","year":"2000","unstructured":"Pau H, Carney AS, Walker R, Murty GE. Is oestrogen therapy justified in the treatment of hereditary haemorrhagic telangiectasia: a biochemical evaluation. Clin Otolaryngol Allied Sci. 2000;25:570\u20136.","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"1533_CR29","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/ajmg.a.36936","volume":"167A","author":"L Pawlikowska","year":"2015","unstructured":"Pawlikowska L, Nelson J, Guo DE, McCulloch CE, Lawton MT, Young WL, et al. The ACVRL1 polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations. Am J Med Genet. 2015;167A:1262\u20137.","journal-title":"Am J Med Genet"},{"key":"1533_CR30","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1093\/hmg\/ddg164","volume":"12","author":"Y Tang","year":"2003","unstructured":"Tang Y, McKinnon ML, Leong LM, Rusholme SA, Wang S, Akhurst RJ. Genetic modifiers interact with maternal determinants in vascular development of Tgfb1(\u2212\/\u2212) mice. Hum Mol Genet. 2003;12:1579\u201389.","journal-title":"Hum Mol Genet"},{"key":"1533_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fgene.2015.00067","volume":"6","author":"TGW Letteboer","year":"2015","unstructured":"Letteboer TGW, Benzinou M, Merrick CB, Quiley DA, Zhau K, Kim IJ, et al. Genetic variation in the functional ENG allele inherited from the non-affected parent associates with presence of pulmonary arteriovenous malformation in hereditary hemorrhagic telangiectasia 1 (HHT1) and may influence expression of PTPN14. Front Genet. 2015;6:67.","journal-title":"Front Genet"},{"key":"1533_CR32","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mgg3.377","volume":"6","author":"L Pawlikowska","year":"2018","unstructured":"Pawlikowska L, Nelson J, Guo DE, CE MC, Lawton MT, Kim H, et al. Association of common candidate variants with vascular malformations and intracranial hemorrhage in hereditary hemorrhagic telangiectasia. Mol Genet Genomic Med. 2018;6:350\u20136.","journal-title":"Mol Genet Genomic Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01533-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-020-01533-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01533-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T08:27:32Z","timestamp":1723624052000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01533-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1533"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01533-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,22]]},"assertion":[{"value":"8 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Patients had given written consent for the study according to the French bioethics law.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript does not contain any individual person\u2019s data in any form. All data are analyzed as aggregates.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"254"}}